About this trial
The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 4 to 17 years followed in the department without an elbow injury
Follow-up schedule compatible with the study protocol
No objection from a parent or legal guardian, with the child's consent if age permits
Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury
Disqualifiers
Language barrier, lack of understanding of French
Refusal to participate
Confounding factor impairing function
Opposition of parent or legal guardian and/or refusal of child if age permits
Trial design
Parallel
Treatments tested in this trial
MEPS-Fr version
DeviceThe MEPS-Fr version will be tested on 120 patients treated either orthopedically or surgically for an elbow injury
Treatment groups
Trial outcomes
Primary outcomes
MEPS-FR score
Mayo Elbow Performance Score (MEPS)
MEPS-FR score
Mayo Elbow Performance Score (MEPS)
MEPS-FR score
Mayo Elbow Performance Score (MEPS)
PREE Score
The Patient-Rated Elbow Evaluation is PREE
Sponsors and contacts
Click on the lead sponsor to view all of their trials.